載入...
Monoclonal Antibody Therapies for Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder
Considerable progress has been made in treatments for multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) over the last several decades. However, the present treatments do not show satisfactory efficacy or safety in a considerable proportion of patients, who experience relapse...
Na minha lista:
| 發表在: | J Clin Neurol |
|---|---|
| Main Authors: | , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Korean Neurological Association
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7354979/ https://ncbi.nlm.nih.gov/pubmed/32657055 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3988/jcn.2020.16.3.355 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|